Depression and quality of life in patients with breast cancer undergoing chemotherapy and monoclonal antibodies

BACKGROUND: Depression is one of the major psychiatric morbidities in cancer patients. The purpose of our study was to evaluate the impact of depressive symptoms in the quality of life (QoL) of patients with breast cancer undergoing chemotherapy and monoclonal antibodies treatments. METHODS: Observa...

Descripción completa

Detalles Bibliográficos
Autores principales: Trinca, Francisco, Infante, Paulo, Dinis, Rui, Inácio, Mariana, Bravo, Emílio, Caravana, Jorge, Reis, Teresa, Marques, Sofia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727885/
https://www.ncbi.nlm.nih.gov/pubmed/31552110
http://dx.doi.org/10.3332/ecancer.2019.937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727885/
https://www.ncbi.nlm.nih.gov/pubmed/31552110
http://dx.doi.org/10.3332/ecancer.2019.937

Ejemplares similares